Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer
Author:
Funder
Merck KGaA
Norwegian Cancer Society
Research Council of Norway
FEDER
Agency for Management of University and Research Grants
AGAUR
Scientific Foundation of the Spanish Association Against Cancer
AECC
NIH
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz287/30040597/mdz287.pdf
Reference26 articles.
1. Colorectal cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013
3. Personalizing colon cancer adjuvant therapy: selecting optimal treatments for individual patients;Dienstmann;J Clin Oncol,2015
4. Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study;Dienstmann;Ann Oncol,2017
5. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis;Mlecnik;Sci Transl Med,2016
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In-depth analysis of prognostic markers associated with the tumor immune microenvironment and genetic mutations in breast cancer based on an NK cell-related risk model;Heliyon;2024-01
2. Development and validation of pathological nomograms for predicting the prognosis of colorectal cancer patients;2023-12-20
3. Multiple programmed cell death patterns and immune landscapes in bladder cancer: Evidence based on machine learning and multi‐cohorts;Environmental Toxicology;2023-12-08
4. Integration of single‐cell and bulk RNA‐sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model;Cancer Reports;2023-11-22
5. Time to start testing KRAS and BRAF V600E mutations in stage III colon cancer? Not in routine care, yet in clinical trials;Annals of Oncology;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3